Biotechnology News

December 26, 2012

MIAMI--(BUSINESS WIRE)--OPKO Health to Expand Latin American Presence with Acquisition of Brazilian Pharmaceutical Company

December 26, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group and AMR in their TreatmentTrends®: Pneumonia (U.S.) report find that for the management of nosocomial pneumonia (NP), the most commonly cited change in treatment practices of surveyed...

December 26, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that William Heiden, AMAG’s chief executive officer, will present at the 31st Annual J.P. Morgan Healthcare Conference on Wednesday, January 9, 2013 at 8...

December 26, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Celator® Pharmaceuticals Enrolls First Patient in Its Phase 3 Study of CPX-351 in Untreated High-Risk Acute Myeloid Leukemia

December 26, 2012

PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) announced today that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved ELIQUIS® (apixaban) for the prevention of...

December 26, 2012

DENVER--(BUSINESS WIRE)--Summarizes a banner year for DaVita, a leading kidney care/dialysis company, in 2012.

December 26, 2012

DUBLIN--(BUSINESS WIRE)--Covidien, a leading global provider of healthcare products, today announced a definitive agreement to acquire CV Ingenuity.

December 26, 2012

GAITHERSBURG, Md.--(BUSINESS WIRE)--OpGen, Inc. today announced its ARGUS® Whole Genome Mapping System technology was used in combination with next-generation sequencing (NGS) to produce the first, high-quality reference genome of the domestic...

December 24, 2012

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc. received the final $2.5M tranche of a total $5M raise announced in June 2012. The funding came from a single investor, namely, Seaside 88, LP.

December 24, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--CorMedix Inc. (“CorMedix”) (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardio renal disease, announced that it...

December 24, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that it has submitted a supplemental new drug application (sNDA) to the United States Food and Drug Administration (FDA) for Feraheme® (ferumoxytol)...

December 24, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that the company amended its development and license agreement with Millennium: The Takeda Oncology Company and Takeda Pharmaceutical Company Limited...

December 21, 2012

SEATTLE--(BUSINESS WIRE)--Dr. Leroy Hood was awarded the National Medal of Science in recognition of his visionary work in science and engineering. He is a world-renowned scientist, inventor, and entrepreneur.

December 21, 2012

EATONTOWN, N.J.--(BUSINESS WIRE)--Flexible Stenting Solutions, Inc. (“FSS”) is pleased to announce that it is now authorized to CE Mark and market its 6 Fr Reconstrainable FlexStent® Self-Expanding Stent System in the European Union. FSS is a...

December 21, 2012

BOULDER, Colo.--(BUSINESS WIRE)--The Shuman Law Firm announces the filing of a securities class action lawsuit against Abiomed, Inc. (Nasdaq: ABMD).

December 21, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has extended the approval of Tamiflu® (oseltamivir phosphate) for...

December 21, 2012

BIRMINGHAM, Ala.--(BUSINESS WIRE)--Celebrity talk show host Suzanne Somers said it’s important to know more about your cholesterol and that the future of advanced medicine lies in the VAP Lipid Panel from Atherotech Diagnostics Lab.

December 21, 2012

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR)(ISIN: IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that, Mr. Thomas Lynch has been...

December 21, 2012

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today announced that the U.S. Food and...

December 21, 2012

BANGALORE, India--(BUSINESS WIRE)--ABLE invites online entries from Innovators to award the Best Biotech Innovations of the 21st Century

December 21, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Open Monoclonal Technology, Inc. (OMT) today announced a discovery collaboration with CNA Development LLC, an affiliate of Janssen Pharmaceuticals, Inc. OMT will employ its OmniRat™ transgenic animal platform...

December 21, 2012

NORTHBROOK, Ill.--(BUSINESS WIRE)--Blue Chip Marketing Worldwide partnered with Orexigen Therapeutics to accelerate enrollment for The Light Study nearly 14 months ahead of forecast

December 21, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it has submitted a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration (FDA) requesting approval for the use of...

December 21, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)--OncoMed Pharmaceuticals advances another anti-cancer stem cell therapy into the clinic and receives a milestone payment from GlaxoSmithKline

December 21, 2012

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) today announced its presentation at the 31st Annual J.P. Morgan Healthcare Conference on January 7, 2013 at 11:00a.m. E.T. will be webcast live and will be available in the...

December 21, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals announced surpassing the primary endpoint in the pivotal, registrational Phase 2 BELIEF trial of belinostat, a pan-histone deacetylase (HDAC) inhibitor.

December 21, 2012

IRVINE, Calif. & REDWOOD CITY, Calif.--(BUSINESS WIRE)--PathCentral Announces Sale of Its Diagnostic Laboratory to Ascend Clinical, LLC; Expands Focus on LIS and Professional Network Business Segments

December 21, 2012

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the Company has completed the acquisition of Neuronex, Inc., a privately held company developing a nasal spray formulation of diazepam. Under the terms...

December 21, 2012

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE:ELN) today announced completion of the separation of a substantial portion of its drug discovery business (the Prothena Business) into a new independent, publicly traded company, Prothena...

December 20, 2012

LOS ANGELES--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today announced that Keith Leonard, President and Chief Executive Officer, will present a corporate overview at the 31st Annual J.P. Morgan Healthcare Conference in San...

December 20, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Radius and 3M announce an exclusive partnership for development and commercialization of BA058-transdermal (TD), a new drug in Phase 2 trials with the potential to treat severe osteoporosis.

December 20, 2012

PASADENA, Calif.--(BUSINESS WIRE)--Bionic Suit Allows Paralyzed Man to Walk at Huntington Hospital

December 20, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (NASDAQ: AVEO) today announced the appointment of Robert Epstein, M.D., M.S. to its Board of Directors, and that Ronald A. DePinho, M.D. will retire from the AVEO Board effective December 31, 2012...

December 20, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX) announced today that it will present at the 31st Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 2013 at 3:00 p.m. (PT). The live webcast of Baxter’s...

December 20, 2012

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Reports Fiscal 2012 Fourth Quarter and Year-End Financial Results

December 20, 2012

PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Euronext Paris - BIO) (Paris:BIO), an innovative Company dedicated to the development of orphan oncology products and to supportive care products, announces the approval of Sitavig...

December 20, 2012

TORONTO--(BUSINESS WIRE)--Procedural growth in the US contrast agent and radiopharmaceutical market will be limited by reimbursement cuts and insurer restriction.

December 20, 2012

BOSTON & NEW YORK--(BUSINESS WIRE)--Humedica, Inc. and Pfizer Inc. (NYSE: PFE) today announced a multi-year strategic alliance to jointly advance capabilities to derive insights from real world data. Humedica, a clinical intelligence company...

December 20, 2012

RAYNHAM, Mass.--(BUSINESS WIRE)--Medrobotics Completes $33.6 Million Series D Financing

December 20, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--During Phase I Clinical trials as the number of visits increases, the cost per patient increases, found Cutting Edge Information.

December 20, 2012

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: In connection with Vitrolife’s (STO:VITR) distribution of the shares in Xvivo Perfusion AB, the Swedish Tax Agency has decided that 77% of the acquisition cost should be allotted to Vitrolife AB...

December 20, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) today announced the appointment of Jeffrey Janus as its Vice President of Sales and Marketing. Mr. Janus’ primary focus will be to create, market, and sell research products for...

December 20, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in the EU5 (France, Germany, Italy, Spain and the United Kingdom), interviewed...

December 20, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC or the “Company”), a leader in the field of regenerative medicine, today announced that its iPS cell-derived human platelet program has been named as one of...